Study Finds discordance between laboratory and CGM-estimated HbA1c

It was a retrospective review of patients with diabetes who use CGM. The researchers used the electronic medical record of the University of Washington to extract eligible encounters. They included a total of 641 separate office encounters of patients who use CGM and had HbA1c and sensor data fewer than 4 weeks apart. They calculated HbA1c-GMI discordance for each subject and assessed for any impact of comorbidities. They determined HbA1c-GMI discordance as the absolute difference between laboratory and eA1C.

Key findings of the study were:

• Among 641 encounters, the researchers identified that 91% had had type 1 diabetes and noted that most patients had diabetes for greater than 20 years.
• They observed that the mean duration of CGM wear was 24.5 ± 8 days.
• They found that only 11% of patients had HbA1c-GMI discordance <0.1%, but 50% and 22% had differences ≥0.5% and ≥1%.
• They noted that the incidence of discordance increased in patients with advanced chronic kidney disease (estimated glomerular filtration rate <60).

The authors concluded, "We found substantial discordance between laboratory and eA1C in a real-world setting. Clinicians need be aware that HbA1c may not as accurately reflect mean glucose as previously appreciated."

For further information:

https://www.liebertpub.com/doi/10.1089/dia.2020.0501